top biopharmaceuticals for glp-1 medication Novo narrows sales outlook as price cuts loom 9 Companies Developing Next-Generation GLP-1

2021 Aug 23;12:721135

Baral KC et al

Related Articles FDA Approves Semaglutide As An Powerful Weight-loss Drug Evolution of GLP1 Receptor Agonists for Diabetes Treatment FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Anti-obesity Medications (AOMs): History And Progress

By enhancing your bodys natural response, GLP-1 medications can help reduce hunger, increase fullness, and support long-term weight management

There is a strong interest in developing obesity treatments based on glucagon-like peptide-1 (GLP-1) agonists, which have proved to limit morbidity and mortality in type 2 diabetes

It does so by giving more convenience and, somehow better patient compliance